Changes in Reproductive Hormone Concentrations Predict the Prevalence and Progression of the Frailty Syndrome in Older Men: The Concord Health and Ageing in Men Project
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
CONTEXT: Frailty, a syndrome of multiple morbidity, weakness, and immobility in aging, is an increasingly urgent threat to public health. Single measures of low serum androgen have been associated with frailty in men, but the contributory role of hormonal changes with time is unassessed. OBJECTIVE: The objective of the study was to examine, using longitudinal measurements, the relations of serum androgens, estrogens, gonadotropins, and SHBG to the prevalence and progression of frailty in older men. DESIGN: Concord Health and Ageing in Men Project is an observational cohort study of 1705 men (aged 70 yr or older) living in the suburb of Concord, Sydney, Australia. Measurements were obtained at baseline (2005-2007) and 2-yr follow-up (2007-2009). Testosterone (T), dihydrotestosterone, estradiol, and estrone were obtained by liquid chromatography-tandem mass spectrometry, whereas SHBG, LH, and FSH were measured by immunoassay. SETTING: Subjects from the general community were sampled. PARTICIPANTS: A total of 1645 subjects constituting a representative sample of community-dwelling men aged 70 yr old or older participated in the study. OUTCOME MEASURES: The frailty syndrome was measured according to the Cardiovascular Health Study (CHS) and Study of Osteoporotic Fractures (SOF) indices. RESULTS: Androgens and estrogens showed significant age-adjusted associations with concurrent frailty. Subjects in the lowest T quintile had 2.2-fold odds of exhibiting greater CHS frailty as compared with the highest T quintile (P < 0.001); results for dihydrotestosterone, estradiol, estrone, and calculated free T were similar, and were unchanged when the SOF frailty index was substituted for the CHS frailty index. A 1 sd, 2-yr decrease in T, calculated free T, or LH was associated with a 1.2- to 1.3-fold increase in the odds of progression (increase in severity) of frailty. The control for comorbid medical conditions did not affect results. CONCLUSIONS: Age-related changes in blood androgens and estrogens may contribute to the development or progression of frailty in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689
Walston, J., Hadley, E. C., Ferrucci, L., Guralnik, J. M., Newman, A. B., Studenski, S. A., Ershler, W. B., Harris, T., & Fried, L. P. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00745.x · Cited by 1,605
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Self-citationPhenotype of frailty: characterization in the women's health and aging studies
Bandeen-Roche, K., Xue, Q.-L., Ferrucci, L., Walston, J., Guralnik, J. M., Chaves, P., Zeger, S. L., & Fried, L. P. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.3.262 · Cited by 1,215 · cited 1×
“There is no consensus on measurement of frailty, but the index described by Fried and colleagues (1, 21) is most widely used in research.”
MethodEnsrud, K. E. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.113 · Cited by 975 · cited 3×
“As in prior studies (22, 23), subjects meeting none of the SOF criteria were considered robust, whereas those meeting one or two or more criteria are termed intermediate/prefrail or frail, respectively.”
BackgroundMethodEnsrud, K. E., Ewing, S. K., Cawthon, P. M., Fink, H. A., Taylor, B. C., Cauley, J. A., Dam, T., Marshall, L. M., Orwoll, E. S., Cummings, S. R., et al. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02137.x · Cited by 636 · cited 2×
“As in prior studies (22, 23), subjects meeting none of the SOF criteria were considered robust, whereas those meeting one or two or more criteria are termed intermediate/prefrail or frail, respectively.”
MethodLow Free Testosterone Predicts Frailty in Older Men: The Health in Men Study
Hyde, Z., Flicker, L., Almeida, O. P., Hankey, G. J., McCaul, K. A., Chubb, S. A. P., & Yeap, B. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2754 · Cited by 286 · cited 9×
“8) 168 (52) 98 (30) 38 (12) 12 (4) 7 (2) (15.”
ResultInfluentialBrambilla, D. J., O'Donnell, A. B., Matsumoto, A. M., & McKinlay, J. B. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02976.x · Cited by 207
Predictive accuracy and sources of variability in calculated free testosterone estimates
Sartorius, G., Ly, L. P., Sikaris, K., McLachlan, R., & Handelsman, D. J. (2009) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008171 · Cited by 175 · cited 1×
“This method exhibits appreciable improvements over other equations in the predictive accuracy of cFT when compared with goldstandard, directly measured free T levels, particularly at low levels that are common in older male populations (34, 35).”
MethodSelf-citationORIGINAL ARTICLE: Accuracy of calculated free testosterone formulae in men
Ly, L. P., Sartorius, G., Hull, L., Leung, A., Swerdloff, R. S., Wang, C., & Handelsman, D. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03804.x · Cited by 172 · cited 1×
“This method exhibits appreciable improvements over other equations in the predictive accuracy of cFT when compared with goldstandard, directly measured free T levels, particularly at low levels that are common in older male populations (34, 35).”
MethodSelf-citationSex Hormones and Frailty in Older Men: The Osteoporotic Fractures in Men (MrOS) Study
Cawthon, P. M., Ensrud, K. E., Laughlin, G. A., Cauley, J. A., Dam, T.-T. L., Barrett-Connor, E., Fink, H. A., Hoffman, A. R., Lau, E., Lane, N. E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0417 · Cited by 157
Cited by
Frailty Assessment in the Cardiovascular Care of Older Adults
Afilalo, J., Alexander, K. P., Mack, M. J., Maurer, M. S., Green, P., Allen, L. A., Popma, J. J., Ferrucci, L., & Forman, D. E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.070 · Cited by 1,173
“testosterone levels (11,12), and insulin resistance (13).”
Physical activity and exercise: Strategies to manage frailty
Angulo, J., El Assar, M., Álvarez-Bustos, A., & Rodríguez-Mañas, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101513 · Cited by 771
Collerton, J., Martin-Ruiz, C., Davies, K., Hilkens, C. M., Isaacs, J., Kolenda, C., Parker, C., Dunn, M., Catt, M., Jagger, C., et al. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.05.005 · Cited by 420
“…in several systems, (Bandeen-Roche et al., 2009; Barzilay et al., 2007; Blaum et al., 2009; Cappola et al., 2009; Leng et al., 2007; Shardell et al., 2009; Travison et al., 2011; Walston et al., 2002), there are few investigations of underlying mechanisms for the Rockwood frailty index.”
BackgroundHigh-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V, Cumming, R. G., Handelsman, D. J., McLachlan, A. J., Abernethy, D. R., Banks, E., & Le Couteur, D. G. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.258 · Cited by 303
Self-citationBuvat, J., Maggi, M., Guay, A., & Torres, L. O. (2013) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02783.x · Cited by 283
Metadata
- Authors
- Travison, T. G., Nguyen, A.-H., Naganathan, V., Stanaway, F. F., Blyth, F. M., Cumming, R. G., Le Couteur, D. G., Sambrook, P. N., & Handelsman, D. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-08
- Volume
- 96
- Issue
- 8
- Pages
- 2464-2474
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2041481588
- Cited by
- 112
- References
- 11
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.